Products / Services

To meet physicians and patients’ needs, we are one of the few companies to successfully build a comprehensive and multi-dimensional product and service portfolio targeting over 20 cancer types covering the entire cycle of cancer early detection and screening, diagnosis, treatment selection and monitoring.    

Genecast CRC

Human KRAS/NRAS/BRAF/PIK3CA Gene Mutation Test Kit


Genecast CRC is the first NGS companion diagnostic kit especially for colorectal cancer approved by national medical products administration (NMPA) in China. The kit detects somatic variants across 29 genes and microsatellite instability (MSI) status, enabling accurate and rapid matching of patients to relevant targeted therapy and immunotherapy regimens.


Key Features and Benefits


  • Comprehensive Coverage

    Targets NCCN guideline-recommended genes with direct therapeutic implications


  • Accurate Data

    >99% consistency with gold standard in clinical samples


  • High Sensitivity

    Detects key cancer driver gene mutations (KRAS/NRAS/BRAF/PIK3CA) with a LOD as low as 1%


Companion Diagnostic Biomarker and Therapy Approved by NMPA


1.1-Genecast CRC 插图1.png


The gene list of Human KRAS/NRAS/BRAF/PIK3CA Gene Mutation Test kit


1.2-Genecast CRC 插图2.png


Specifications


1.2-Genecast CRC 插图2.png